India Share Brokers | Equity Trading India | Derivative Trading in India | Share Brokers in India

Markets Navigation

Company Info.

Titan Biotech Ltd.

Income Statement - Consolidated

Market Cap.(`)	376.37 Cr.	P/BV	2.74	Book Value (`)	166.49
52 Week High/Low ( ` )	1018/407	FV/ML	10/1	P/E(X)	15.14
Book Closure	30/09/2024	EPS (`)	30.07	Div Yield (%)	0.44

(` in Crs.)

You can view the Consolidated Income Statement for the last 5 years.

Particulars	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	164.07	144.00	152.81	142.24	79.44
Total Operating Revenues	164.07	144.00	152.81	142.24	79.44

Other Income	1.75	1.94	1.02	0.79	0.45
Total Revenue	165.82	145.94	153.83	143.03	79.89

EXPENSES
Cost Of Materials Consumed	80.89	70.81	75.48	67.30	40.24
Operating And Direct Expenses	18.13	15.77	12.24	10.72	8.29
Changes In Inventories Of FG,WIP And Stock-In Trade	-5.29	-0.93	-0.60	-2.73	-0.89
Employee Benefit Expenses	23.71	18.21	16.14	14.05	12.47
Finance Costs	1.17	0.75	1.28	1.67	2.34
Depreciation And Amortisation Expenses	3.33	2.60	2.54	2.22	1.80
Other Expenses	12.34	10.63	8.56	6.77	5.85
Total Expenses	134.29	117.83	115.63	100.00	70.10

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	31.53	28.12	38.20	43.03	9.79

Exceptional Items	0.00	0.00	0.00	-0.32	0.61
Profit/Loss Before Tax	31.53	28.12	38.20	42.71	10.40

Tax Expenses-Continued Operations
Current Tax	7.79	7.21	9.70	10.86	2.39
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.03
Deferred Tax	0.11	-0.09	-0.07	0.14	0.20
Tax For Earlier Years	-0.03	-0.03	0.02	0.01	0.00
Total Tax Expenses	7.87	7.09	9.65	11.00	2.57
Profit/Loss After Tax And Before ExtraOrdinary Items	23.66	21.02	28.55	31.71	7.84

Profit/Loss From Continuing Operations	23.66	21.02	28.55	31.71	7.84

Profit/Loss For The Period	23.66	21.02	28.55	31.71	7.84

Minority Interest	0.00	0.00	0.00	-1.37	-0.77
Share Of Profit/Loss Of Associates	1.19	3.82	0.19	0.00	0.00
Consolidated Profit/Loss After MI And Associates	24.85	24.84	28.74	30.34	7.07

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	30.07	25.44	30.66	36.71	8.55
Diluted EPS (Rs.)	30.07	25.44	30.66	36.71	8.55

DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	1.49	1.24	1.24	0.83	0.00

Titan Biotech Ltd.

Balance Sheet - Consolidated

Market Cap.(`)	376.37 Cr.	P/BV	2.74	Book Value (`)	166.49
52 Week High/Low ( ` )	1018/407	FV/ML	10/1	P/E(X)	15.14
Book Closure	30/09/2024	EPS (`)	30.07	Div Yield (%)	0.44

(` in Crs.)

You can view the Consolidated Balance Sheet for the last 5 years.

Particulars	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00
No. of Equity Shares (in Lacs)	82.64	82.64	82.64	82.64	82.64

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	8.26	8.26	8.26	8.26	8.26
Total Share Capital	8.26	8.26	8.26	8.26	8.26

Reserves and Surplus	125.19	101.65	90.40	60.49	30.93
Total Reserves and Surplus	125.19	101.65	90.40	60.49	30.93
Total Shareholders Funds	133.45	109.91	98.67	68.76	39.19
Minority Interest	0.00	0.00	6.74	3.72	2.35

NON-CURRENT LIABILITIES
Long Term Borrowings	0.45	0.30	8.40	4.86	11.55
Deferred Tax Liabilities [Net]	1.37	1.21	1.31	1.39	1.23
Other Long Term Liabilities	0.69	1.13	1.55	1.40	0.00
Long Term Provisions	1.48	1.62	1.51	1.49	1.28
Total Non-Current Liabilities	4.00	4.25	12.76	9.13	14.06

CURRENT LIABILITIES
Short Term Borrowings	6.72	6.70	7.47	8.29	11.34
Trade Payables	3.37	5.55	7.55	3.71	4.12
Other Current Liabilities	8.48	7.77	9.92	7.11	4.97
Short Term Provisions	0.56	0.33	0.29	0.00	0.00
Total Current Liabilities	19.13	20.35	25.23	19.11	20.43

Total Capital And Liabilities	156.58	134.52	143.40	100.72	76.04

ASSETS
NON-CURRENT ASSETS
Tangible Assets	51.94	35.81	42.05	33.51	31.06
Intangible Assets	0.07	0.09	0.10	0.09	0.10
Capital Work-In-Progress	2.53	13.29	7.97	0.27	0.07
Intangible Assets Under Development	0.02	0.00	0.00	0.00	0.00
Fixed Assets	54.56	49.19	50.12	33.88	31.23
Non-Current Investments	28.19	15.41	0.00	0.00	0.00
Other Non-Current Assets	1.65	1.62	1.93	7.51	0.61
Total Non-Current Assets	84.41	66.21	52.05	41.39	31.84


CURRENT ASSETS
Inventories	45.57	36.17	42.29	32.54	27.98
Trade Receivables	18.66	21.01	21.67	18.10	11.86
Cash And Cash Equivalents	2.84	4.86	15.61	5.63	1.86
OtherCurrentAssets	5.11	6.26	11.78	3.05	2.50
Total Current Assets	72.17	68.31	91.35	59.33	44.20

Total Assets	156.58	134.52	143.40	100.72	76.04

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	12.90	1.13	3.20	0.38	0.00

NON-CURRENT INVESTMENTS
Non-Current Investments Unquoted Book Value	28.19	15.41	0.00	0.00	0.00

Attention Investors : “Prevent unauthorized transactions in your account ? Update your Mobile Numbers/Email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your Mobile/Email at the end of the day. Issued in the interest of Investors” ***** No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. | | ***** KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. | "Revised guidelines on margin collection ==> 1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. | 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. | 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. | 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors" | ***** MEMBERS : SEBI Regn. No: NSE, BSE: INZ000176636 ; MCX : INZ000057535; SEBI Research Analyst Regn No: INH200000337; AMFI Regn No. 77624; Depository Participant : CDSL : IN-DP-CDSL-379-2006 DP ID : 12047600 | For any Grievance mail to : grievance@sharewealthindia.com | For any DP Grievance mail to : dpgrievance@sharewealthindia.com. | Grievance with SEBI : https://scores.gov.in/scores/Welcome.html

Share Wealth

Titan Biotech Ltd.

Income Statement - Consolidated

Titan Biotech Ltd.

Balance Sheet - Consolidated